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Abstract Munc18c has been shown to bind syntaxin 4 and to
play a role in GLUT4 translocation and glucose transport,
although this role is as yet poorly de¢ned. In the present study,
the e¡ects of modulating the available level of munc18c on
glucose transport and GLUT4 translocation were examined.
Over-expression of munc18c in 3T3L1 adipocytes inhibited in-
sulin-stimulated glucose transport by approximately 50%. Basal
glucose transport rates were also decreased by approximately
25%. In contrast, microinjection of a munc18c polyclonal anti-
body stimulated GLUT4 translocation by approximately 60%
over basal levels without a¡ecting insulin-stimulated GLUT4
levels. Microinjection of a control antibody had no e¡ect. These
data are consistent with the likelihood that antibody micro-
injection sequesters munc18c enabling translocation/fusion of
GLUT4 vesicles. Mutagenesis of a potential proline-directed
kinase phosphorylation site in munc18c, T569, that in previous
studies of its neuronal counterpart munc18a caused its dissoci-
ation from its complex with syntaxin 1a, had no e¡ect on
munc18c’s association with syntaxin 4 or its inhibition of glu-
cose transport, indicative that phosphorylation of this residue is
not important for insulin regulation of glucose transport. The
over-expression and microinjection sequestration data support
an inhibitory role for munc18c on translocation/fusion of
GLUT4 vesicles. They further show that altering the level of
available munc18c in 3T3L1 cells can modulate glucose trans-
port rates, indicating its potential as a target for therapeutics in
diabetes. 4 2002 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Insulin stimulation of glucose transport in insulin-sensitive
tissues results predominantly from the translocation of
GLUT4 transporters from a pool within tubovesicular mem-
brane structures in the cell, to the cell surface, through a
process that shares some similarities with regulated exocytosis
(see [1,2] for review). In particular, proteins involved in dock-
ing and fusion of exocytic vesicles with the cell surface are
present in insulin-sensitive cells and have been implicated in
insulin-dependent GLUT4 tra⁄cking [2^4]. These proteins in-
clude vesicle associated membrane protein 2 (VAMP2), syn-
taxin 4 and synaptosome associated protein of 23 kDa
(SNAP23), whose counterparts in neural cells comprise the
fusogenic machinery for regulated tra⁄cking of neurotrans-
mitter to nerve terminals. Vesicles containing vesicle soluble
N-ethylmaleimide-sensitive factor attachment protein recep-
tors (vesicle SNAREs; VAMP2 in GLUT4 translocation) on
their surface interact with their cognate target SNAREs (syn-
taxin 4 and SNAP23 in GLUT4 translocation) on the plasma
membrane in a highly speci¢c manner. This speci¢city was
initially believed to be controlled by cellular compartmental-
isation and speci¢city of the di¡erent SNARE proteins in-
volved. However, it was recently demonstrated that non-cog-
nate SNARE proteins could form complexes in vitro and the
properties of these complexes were similar regardless of
whether the SNARE proteins were closely or distantly related
[5]. This implies that speci¢city and membrane fusion must be
controlled by additional events. These events could be medi-
ated through a variety of regulatory proteins including
munc18c [5^12], synip [13] and/or GTP binding proteins
such as Rab4 [14].
The munc18 family are syntaxin binding proteins and are
the mammalian homologues of the yeast Sec1 and Caenorhab-
ditis elegans Unc18 proteins, but their role remains largely
unde¢ned. They apparently have a critical role in vesicle dock-
ing, fusion and/or exocytosis, since null or temperature-sensi-
tive mutations in yeast and/or Drosophila homologues mark-
edly inhibit vesicle exocytosis [15^17]. Equally, an inhibitory
e¡ect on vesicle fusion is evident from studies that show that
over-expression of munc homologues inhibits exocytosis
[9,10,18]. Understanding the nature of munc interactions
with its binding partners and the processes it regulates will
clearly provide further insight into understanding vesicle fu-
sion and/or exocytosis events.
To date three mammalian munc18 homologues have been
identi¢ed; munc18a, b and c [11,19^21]. Munc18a and b in-
teract with syntaxin 1, 2 and 3. Munc18c interacts with syn-
taxin 4, the syntaxin homologue shown to be of importance
for fusion of GLUT4 vesicles with the plasma membrane, and
to a lesser extent syntaxin 2. In neuronal cells, the binding of
munc18 to syntaxin prevents syntaxin forming a SNARE
complex with VAMP and SNAP25. In 3T3L1 adipocytes,
consistent with these data, over-expression of munc18c inhib-
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its insulin-stimulated glucose transport and GLUT4 translo-
cation [8,10].
Studies with the neuronal munc homologue, munc18a, dem-
onstrated greatly reduced syntaxin binding capacity when
phosphorylated by protein kinase C [22], although phosphor-
ylation could not be demonstrated when munc18a was already
bound to syntaxin. More recently, cyclin-dependent kinase 5
was found to directly associate with munc18a, phosphorylate
T574 and induce disassembly of munc18a from syntaxin:
munc18a heterodimer complexes [23]. This phosphorylation
thus provides a potential site for regulation of fusion. Inter-
estingly, this site (HILTPQK), and surrounding residues, is
conserved in all mammalian homologues of munc18, includ-
ing munc18c (HILTPRK), indicating that regulation of phos-
phorylation of this site could be of importance in mediating
available levels of munc for regulation of activities such as
glucose transport.
In the present study, the nature of munc18c involvement in
GLUT4 translocation and glucose transport is investigated by
examining the e¡ect of modulating the available level of
munc18c. We show that lowering endogenous munc18c levels
by microinjection of munc18c antibody stimulated GLUT4
translocation to the plasma membrane. We con¢rm that
over-expression of munc18c inhibits insulin-stimulated glucose
transport. We further show that mutagenesis of T569 in
munc18c (equivalent to T574 in munc18a) to alanine, serine
or glutamic acid fails to a¡ect munc inhibition of glucose
transport, indicating that regulation of available munc18c
binding activity is unlikely to be manifested through phos-
phorylation of this site. These data taken together thereby
demonstrate that the level of cellular munc18c can modulate
glucose transport rate and are of importance for consideration
of potential therapeutics for increasing glucose transport rate
in the treatment of type 2 diabetes.
2. Materials and methods
2.1. Antibodies
Immunopuri¢ed munc18b and 18c rabbit polyclonal antibodies
were gifts from Professor David James (University of Queensland,
St. Lucia, Qld, Australia). 9E10 anti-c-myc monoclonal antibody
was used to detect c-myc-epitope tagged munc18c expression. Gluta-
thione-S-transferase (GST)^syntaxin 4 was detected with a GST poly-
clonal antibody from Amrad Biotech, Australia.
2.2. Constructs and plasmid preparation
Full-length mouse munc18c (residues 1^592), GenBank accession
number U19521; a gift from Professor David James, University of
Queensland, St. Lucia, Qld, Australia) was subcloned into pCR
Script1 (Stratagene) and a c-myc tag inserted into the N-terminus.
Mutagenised constructs (T569A, T569S and T569E) were prepared
using the QuikChange1 Site-Directed Mutagenesis kit (Stratagene)
according to the manufacturer’s instructions. Mutagenised constructs
were subcloned back into munc18cWT (wild type) as PstI/BamHI
fragments and the resulting constructs checked by restriction analysis
and sequencing. WT and mutant munc18c constructs were subcloned
into pLXIN (Clontech) for retroviral infection of 3T3L1 ¢broblasts.
Each construct was excised out of pCR Script as a blunt-ended XhoI/
BamHI fragment and subcloned into the HpaI/BamHI sites of pLXIN
maintaining the 5P c-myc tag in munc18c. Correct insertion of the
munc18c sequence was checked by restriction enzyme analysis.
2.3. Cell culture
3T3L1 ¢broblasts obtained from the American Type Culture Col-
lection (Rockville, MD, USA) were maintained and passaged as pre-
con£uent cultures in Dulbecco’s modi¢ed Eagle’s medium (Sigma)
with 5% foetal calf serum (CSL, Australia). Cells were di¡erentiated
into adipocytes for study as previously described [4].
2.4. Retroviral infection and transfection
Munc18c constructs were retrovirally infected into 3T3L1 ¢bro-
blasts after generation of virus in BOSC23 cells using the replica-
tion-incompetent retroviral vector, pLXIN (Clontech). Cells were
maintained under G418 selection and used as mixed populations. In-
fection e⁄ciency (s 70%) was monitored with parallel infections us-
ing virus from BOSC23 cells transfected with pLEIN (Clontech,
pLXIN vector encoding enhanced green £uorescent protein). For ex-
periments, 3T3L1 cells were used in the di¡erentiated state.
2.5. GST-syntaxin 4 puri¢cation
A GST fusion protein consisting of the cytoplasmic portion of
syntaxin 4, GST^syntaxin 42273, was produced in Escherichia coli
and puri¢ed as described previously [6,24].
2.6. Cell lysis, immunoprecipitation and in vitro binding studies
Cells in 55 cm2 dishes were washed twice with phosphate bu¡ered
saline (PBS), pH 7.4, and then lysed by the addition of 800 Wl/dish of
50 mM N-(2-hydroxyethyl)piperazine-NP-(2-ethanesulfonic acid)
(HEPES) bu¡er, pH 7.2, containing 150 mM NaCl, 1 mM EGTA,
10% glycerol, 1% Triton X-100, 200 U/ml aprotinin, 10 Wg/ml leupep-
tin, 1 Wg/ml pepstatin and 2 mM phenylmethylsulphonyl £uoride es-
sentially as detailed previously [25]. Dishes were incubated 5 min on
ice, the lysate collected, incubated a further 5 min on ice and then
clari¢ed by centrifugation at 12 500Ug for 2 min. munc18cWT or
mutants in the supernatants were immunoprecipitated by incubation
overnight at 4‡C with 2 Wg/ml puri¢ed 9E10 anti-c-myc monoclonal
antibody and 20 Wl of protein A^Sepharose (Zymed, CA, USA)
slurry. The Sepharose beads were pelleted by centrifugation, washed
three times in 0.5 ml 20 mM HEPES, pH 7.2, 150 mM NaCl, 0.1%
Triton X-100 and 10% glycerol (HNTG bu¡er), and munc18c prepa-
rations used for interaction assay with GST^syntaxin 42273 or for
SDS^PAGE and Western transfer. For interaction assay, the immu-
noprecipitate from one 55 cm2 dish was incubated for 90 min at 4‡C
with 10 Wg GST^syntaxin 42273. The immunoprecipitate was then
washed four times with PBS and syntaxin 4 binding to munc18c
detected, after SDS^PAGE and Western transfer of the immunopre-
cipitates, by probing blots with anti-GST polyclonal antibody with
enhanced chemiluminescence detection with SuperSignal0 (Pierce, IL,
USA). In one experimental series, total cell lysates (equivalent of
0.025 of a dish of cells) were analysed by SDS^PAGE, Western trans-
fer and blotting with munc18c polyclonal antibody.
2.7. Microinjection and GLUT4 translocation assay
Our procedure for microinjection of 3T3L1 adipocytes and quanti-
tation of insulin-stimulated GLUT4 translocation by confocal micros-
copy has been described elsewhere [4,11]. Brie£y, cells grown to con-
£uence and di¡erentiated on coverslips were transferred for 45 min to
Krebs^Ringer bicarbonate HEPES bu¡er, pH 7.4, containing 2 mM
pyruvate, 0.5% bovine serum albumin (BSA) and 2.5 mM glucose.
Antibody in bu¡er containing 5 mM sodium phosphate (pH 7.2),
100 mM KCl or bu¡er alone was microinjected over a 45 min period
using a Zeiss automated injection system (Carl Zeiss, Germany)
coupled to an Eppendorf (Germany) microinjector. Cells were trans-
ferred into fresh medium and allowed to recover for 60^90 min fol-
lowing injection, prior to stimulation with 100 nM insulin for 15 min
and analysis of GLUT4 translocation using the plasma membrane
lawn assay. Plasma membrane GLUT4 levels in microinjected cells
were compared to that in non-injected cells in the immediate vicinity
on the same coverslip as described previously [26,11]. Brie£y, after cell
treatment, 3T3L1 cells grown on coverslips were washed sonicated
and the membrane fragments immunolabelled with polyclonal rabbit
anti-GLUT4 antibody (R1159, 1/100) [27] and either Alexa 488 goat
anti-rabbit (Molecular Probes) or CY3-labelled goat anti-rabbit anti-
body (Amersham, UK). Coverslips were visualised and imaged using
a BioRad (USA) Lasersharp MRC-500 confocal laser scanning im-
muno£uorescence microscope or Optiscan F900e Confocal micro-
scope. Data were analysed using either BioRad COMOS confocal
imaging software or ImageJ. E¡orts were made to maintain confocal
microscope gain settings over the period of experiments although
alterations in these as well as di¡erences in 3T3L1 populations con-
tribute to between-experiment variability.
2.8. Glucose transport assay
Glucose transport was measured as 2-deoxy-[U-14C]glucose uptake
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as previously described [28]. Cells at least 48 h post-di¡erentiation in
24-well plates were washed twice in Krebs^Ringer bicarbonate
HEPES bu¡er, 1% BSA, 2 mM pyruvate, containing half the normal
Ca (1.15 mM CaCl2Þ, pH 7.4, and then allowed to equilibrate in the
incubator for 90 min. Insulin was added over the concentration range
0.7^70 nM for 30 min and 5 mM 2-deoxy-[U-14C]glucose uptake mea-
sured over the ¢nal 10 min.
3. Results
3.1. E¡ect of microinjection of anti-munc18c antibodies
on GLUT4 translocation to the plasma membrane
of 3T3L1 adipocytes
We previously showed, using an antibody microinjection
Fig. 1. Microinjection of munc18c antibody stimulates GLUT4 translocation. 3T3L1 adipocytes were preincubated in Krebs^Ringer bu¡er pH
7.4 for 45 min and then microinjected with bu¡er, anti-munc18c, anti-munc18b or control antibody as described in Section 2. The cells were
transferred to fresh bu¡er and allowed to recover for 90 min prior to incubation for 15 min in the presence or absence of 100 nM insulin.
A: GLUT4 translocation was determined by the plasma lawn assay. Results are expressed as ‘percent of basal cell surface GLUT4’. They
represent the meanVS.E.M. of 6^11 experiments in which four or more separate ¢eld determinations were analysed within any single experi-
ment. *P6 0.05 vs. minus insulin control (repeated measures, analysis of variance). Insulin-stimulated plasma membrane levels of GLUT4 in
microinjected cells did not di¡er signi¢cantly from insulin-stimulated cells that had not been microinjected. B: Representative lawns for each
condition.
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approach, that syntaxin 4 plays a role in translocation of
GLUT4 to the plasma membrane of 3T3L1 adipocytes [11].
In those studies, microinjection of a syntaxin 4 antibody
blocked insulin-dependent GLUT4 translocation in this cell
type by about 70% over control. A similar approach was
used in the present study to assess the e¡ects of disruption
of munc18c function on GLUT4 translocation in 3T3L1 adi-
pocytes (Fig. 1). A polyclonal munc18c antibody, described
previously [11], was microinjected into 3T3L1 adipocytes prior
to stimulation with insulin. The plasma membrane lawn assay
was then used to quantitate cell surface GLUT4 levels. We
had previously established that microinjection per se did not
a¡ect GLUT4 translocation in these cells. Injection of the
munc18c antibody increased plasma membrane GLUT4 levels
by approximately 60% over control in the absence of insulin
(P6 0.002), whereas an unrelated control antibody had no
e¡ect (Fig. 1). The same e¡ect was seen using a di¡erent poly-
clonal munc18c antibody raised against the C-terminal por-
tion of munc (data not shown). Moreover, the e¡ect observed
was speci¢c for munc18c, since an antibody directed against
another munc homologue, munc18b, failed to increase the
level of GLUT4 at the plasma membrane. The e¡ect of
munc18c was not additive to that of insulin since munc18c
antibody microinjection failed to stimulate GLUT4 transloca-
tion over that caused by insulin addition alone. Thus, inter-
ference of munc18c function in£uences GLUT4 appearance at
the plasma membrane.
3.2. Expression of munc18c and T569 munc18c mutants in
3T3L1 cells
Since sequestration of munc18c with munc18c antibodies
stimulated GLUT4 translocation, it was of interest to assess
the e¡ects of over-expression of munc18c in 3T3L1 adipo-
cytes. Additionally, the role of T569 in regulating munc18c
binding activity was assessed since phosphorylation of the
conserved equivalent residue in munc18a, T574, was found
to cause its dissociation from syntaxin in chroma¢n cells
[23]. We had previously not been able to demonstrate signi¢-
cant phosphorylation of munc18c in 3T3L1 cells (unpub-
lished) but this does not preclude transient phosphorylation
as a regulatory mechanism in munc18c activity. We therefore
generated 3T3L1 cells over-expressing munc18c, munc18c-
T569A, T569S, or T569E, by retroviral infection and selection
with neomycin. These cell lines were assessed as pooled pop-
ulations. Immuno£uorescence studies with 9E10 anti-c-myc
epitope monoclonal antibody indicated that each mutant
had a similar distribution pattern to that of munc18cWT,
predominantly cytosolic with additional foci of staining at
the periphery (data not shown) similar to the subcellular local-
isation of wild type munc18c we reported previously [11]. Im-
munoprecipitation and Western blot analysis with 9E10 anti-
body con¢rmed the expression of munc18c and each of the
munc18c mutants at the expected molecular weight of approx-
imately 65 kDa (Fig. 2A). The 9E10 antibody heavy chain
was also detected at V50 kDa. Co-precipitation of endoge-
nous syntaxin 4 with munc18c was detected by immunoblot-
ting these immunoprecipitates with a syntaxin 4 antibody, but
only weakly (data not shown). Western blots of total cell
lysates were probed with munc18c polyclonal antibody (Fig.
2B). Both c-myc epitope^munc18c (upper band) and endoge-
nous munc18c (lighter lower band) were detected in cell ly-
sates from each of the cell lines except for the empty vector
transfected cell line that expressed only endogenous munc18c
as expected. The c-myc epitope^munc18c ran at a slightly
higher molecular weight than endogenous munc18c and was
expressed at levels ¢ve- to 10-fold higher than endogenous
munc18c (Fig. 2B).
To assess the binding of syntaxin 4 to each of the munc18c
mutants, munc18c proteins isolated from 3T3L1 adipocytes
by immunoprecipitation with 9E10 were incubated with a re-
combinant GST-fusion protein encompassing the cytoplasmic
portion of syntaxin 4 (GST^syntaxin 42273). GST^syntaxin
42273 association with the immunoprecipitated c-myc-
munc18c was analysed after extensive washing by SDS^
PAGE, transfer to nitrocellulose and immunoblotting with a
GST antibody (Amrad Biotech, Australia) (Fig. 3). GST^syn-
taxin 42273 bound each of the constructs approximately
equivalently. No GST^syntaxin 42273 binding was detected
Fig. 2. Western blot analysis of 3T3L1 cells infected with retrovirus
encoding munc18cWT and T569 mutations. Cell lysates were pre-
pared from 3T3L1 cells infected with virus encoding munc18cWT,
munc18cT569A, munc18cT569S or munc18cT569E. Empty vector
(pLXIN) was used as a negative control. A: Munc18c in each lysate
was immunoprecipitated overnight at 4‡C with 2.5 Wg 9E10 anti-
myc antibody and 20 Wl protein A^Sepharose and analysed by
SDS^PAGE, Western transfer and blotting with c-myc antibody,
9E10. The lower band at V50 kDa represents the heavy chain of
the immunoprecipitating antibody. The upper band, c-myc-munc18c,
is indicated. B: Total cell lysate from each cell line was analysed by
SDS^PAGE, Western transfer and blotting with munc18c polyclonal
antibody. The upper band, c-myc-munc18c, is indicated, as is en-
dogenous munc18c running as a fainter band slightly below the
myc-tagged protein.
Fig. 3. Munc18cWT and T569 mutants bind to GST^syntaxin
42273 in vitro. c-Myc-tagged munc18cWT and mutants were ex-
tracted from 3T3L1 cells expressing each construct by immunopre-
cipitation with 9E10 anti-myc antibody. Control analyses included
immunoprecipitates from 3T3L1 cells infected with virus packaged
from empty vector transfected BOSC cells (second last lane,
pLXIN), and 9E10 bound protein A^Sepharose alone (last track,
Nil). Each immunoprecipitate was incubated with 10 Wg GST^syn-
taxin 42273 for 90 min at 4‡C. The immunoprecipitates were then
washed four times with PBS and syntaxin 4 binding to munc18c de-
tected, after SDS^PAGE and Western transfer of the immunopreci-
pitates, by probing blots with anti-GST polyclonal antibody.
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to the extract from the vector control or to protein A^Seph-
arose alone. There was also no binding of GST to munc18c
(data not shown) as demonstrated in our earlier studies [6].
Interestingly, pre-incubation of the c-myc-munc18c cell lysates
with polyclonal munc18c antibody prior to immunoprecipita-
tion and GST^syntaxin 42273 binding failed to markedly af-
fect its binding to c-myc epitope^munc18c (data not shown),
suggesting the binding epitopes lie in regions outside the syn-
taxin binding region of munc18c.
3.3. E¡ects of over-expression of munc18c mutants on glucose
transport and GLUT4 translocation
The e¡ect of over-expression of each of the munc18c mu-
tants on glucose transport in 3T3L1 cells was examined over a
range of insulin concentrations (Fig. 4). Insulin caused an
approximately four-fold stimulation of glucose transport in
both 3T3L1 cells and 3T3L1 cells infected with virus from
BOSC23 cells transfected with the empty vector. Insulin-
stimulated glucose transport in cells transfected with c-myc-
tagged munc18c was only half that of non-infected or vector
alone infected cells at all concentrations of insulin tested.
Basal glucose transport rate was also lower than empty vector
infected or non-infected cells. Insulin stimulation of glucose
transport and basal glucose transport rates for each of the
mutant munc18c-expressing cell lines were similar to that of
wild type munc18c-expressing cell line, consistent with the
lack of e¡ect of these mutations on the binding to syntaxin
seen in the initial studies.
The e¡ects of insulin on glucose transport are manifested
primarily through the translocation of GLUT4 to the cell
surface. The e¡ects of over-expression of each of the munc
mutants in 3T3L1 adipocytes on GLUT4 translocation were
therefore determined at maximal insulin concentration
(70 nM) (Fig. 5). Insulin stimulated GLUT4 translocation
more than four-fold in 3T3L1 adipocytes from cells infected
with virus from BOSC cells transfected with pLXIN vector
alone. Cells expressing c-myc epitope^munc18c, and each of
the munc18c mutants, had diminished responses to insulin of
35^65% in the assay shown, consistent with the e¡ects of
insulin on glucose transport shown in Fig. 4.
4. Discussion
In this study we show that modulating the level of munc18c
in 3T3L1 adipocytes can alter glucose transport rate and
GLUT4 translocation. Over-expression of munc18c inhibited
glucose transport, con¢rming previous reports [8,10,29]. Mi-
croinjection of munc18c antibody into 3T3L1 cells, which we
infer depletes available munc18c, stimulated GLUT4 translo-
cation. The modulation of glucose transport and GLUT4
translocation by manipulating munc18c protein levels sup-
ports a potential regulatory role for munc18c protein levels
in mediating fusion/translocation of GLUT4 vesicles to the
cell surface. This activity of munc does not appear to be
mediated through phosphorylation of T569 since munc18c
mutants lacking the phosphorylation site, munc18cT569A,
or a mutant designed to mimic phosphorylation with respect
to size and charge, munc18cT569E, failed to a¡ect syntaxin 4
binding to munc18c. Consistent with these data, over-expres-
sion of each of these mutants inhibited insulin-stimulated glu-
cose transport and GLUT4 translocation to a similar extent
as over-expression of wild type munc18c.
The lack of e¡ect of the munc18c mutations on syntaxin 4
binding and on munc inhibition of glucose transport is per-
haps surprising given previous ¢ndings [23,30], demonstrating
that munc18a phosphorylation at the equivalent site displaced
syntaxin 1a binding and the fact that sequences of munc iso-
forms are highly conserved. However, a number of observa-
tions make it unlikely that munc18c binds syntaxin 4 through
an interaction encompassing T569. First, the crystal structure
of the munc18a/syntaxin 1 complex shows no contact in this
region [31]. Structural similarity between munc18c and
munc18a would be expected since the alignment of munc18c
with munc18a is similar throughout (51% identity) and par-
ticularly in the region of T569 [12]. Second, we previously
showed that residues 1^139 of munc18c are su⁄cient for bind-
ing to syntaxin 4 [6], consistent with the structure reported for
syntaxin 1 binding to munc18a. The major sites in munc18a
Fig. 4. E¡ect of insulin on glucose transport in 3T3L1 adipocytes
expressing munc18cWT and T569 mutations. 3T3L1 cells expressing
munc18cWT or each of the munc18cT569 mutations were incubated
in the presence or absence of the indicated concentrations of insulin
for 20 min prior to the measurement of 2-deoxy[U-14C]glucose up-
take over the following 10 min. Results are expressed as the
meanVS.E.M. from six to seven independent experiments in which
three independent cell incubations were performed within each ex-
periment for each point. In each case, insulin signi¢cantly stimulated
glucose transport at the lowest concentration tested, 0.07 nM,
P6 0.05. Cells over-expressing munc18cWT or the T569 mutations
showed a signi¢cantly impaired response to insulin compared to
3T3L1 cells at all concentrations, P6 0.05. Empty vector pLXIN in-
fected cells were not di¡erent from non-infected 3T3L1 cells.
Fig. 5. E¡ect of insulin on GLUT4 translocation in 3T3L1 adipo-
cytes expressing munc18cWT and T569 mutations. 3T3L1 cells ex-
pressing munc18cWT or each of the munc18cT569 mutations were
incubated in the presence or absence of 70 nM insulin for 20 min
prior to the measurement of plasma membrane GLUT4 levels as de-
scribed in Section 2. Results are meanVS.E.M. of ¢ve or more
¢elds within the same experiment. *P6 0.05 vs. insulin-stimulated
pLXIN empty vector infected cells. Similar results were obtained in
two separate experiments.
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for interaction with syntaxin 1 were found to be located in
domain 1 (residues 4^134) (similar to our ¢ndings for
munc18c) and some residues in domain 3 [31]. In this struc-
ture, syntaxin 1a adopts a closed conformation with its
N-terminus interacting with its C-terminus. Removal of
munc may allow syntaxin to adopt an open conformation
for binding to SNAP25 and VAMP2, thus enabling mem-
brane fusion. However, free syntaxin has been shown to adopt
a closed conformation in solution similar to its munc-bound
form [32]. The T569 site is buried within domain 2, away from
this syntaxin-binding domain. Thus, if important, T569 could
represent a site of interaction for other e¡ectors such as Rab
proteins. Supporting a role for this region is the ¢nding that a
C-terminal 20 amino acid munc18a peptide stimulated insulin
secretion from HIT cells [33]. These authors suggested that the
peptide potentially disrupted a Rab protein interaction. Our
studies do not rule out a potential e¡ect of phosphorylation of
T569 to a¡ect the binding of a munc e¡ector such as a Rab to
potentiate fusion since the inhibitory e¡ects of munc over-
expression would be expected to dominate. However, the
data show that modi¢cation of this residue is unlikely to di-
rectly a¡ect syntaxin binding.
The stimulation of GLUT4 appearance at the plasma mem-
brane by munc18c antibody microinjection is consistent with
the possibility that the antibody caused dissociation of the
munc18c:syntaxin 4 complex, freeing syntaxin to interact
with SNAP23 and VAMP2 to enable fusion. A previous study
in HIT cells demonstrated that administration of a munc18a
antibody stimulated insulin release [33], consistent with our
studies and this interpretation for munc18c. These ¢ndings
are important since they indicate that manipulating munc18c
availability can both positively and negatively a¡ect glucose
transport. An alternative possibility is that the antibody bind-
ing altered the conformation of munc18c making it competent
for fusion. This possibility is unlikely, given that one antibody
used was directed toward the C-terminal amino acids and
therefore a small epitope. Further, reports of conformational
change induced by antibodies in homeotypic protein interac-
tions are rare.
In addition to the inhibitory e¡ect of munc on SNARE
complex formation suggested above, munc has also been as-
cribed an essential chaperone role for syntaxin and a further
potentiating role in fusion. Deletion of munc homologues in
yeast or mammalian cells resulted in a block of vesicle trans-
port [34,35]. Deletion of the yeast munc homologue, Vps45p,
was furthermore shown to cause rapid proteosomal degrada-
tion of its target SNARE, Tlg2p [35]. Active participation of
munc homologues in the fusion process has also been sug-
gested [8,35,36]. Thurmond et al. [8] showed that introduction
into 3T3L1 cells of a peptide corresponding to the predicted
exteriorised loop between domains 2 and 3 of munc made cells
competent to translocate GLUT4 following an insulin stimu-
lus without enabling fusion. In this case, GLUT4 aligned in
storage vesicles just below the plasma membrane. Similarly,
Dresbach et al. [36] showed that microinjection of C-terminal
portion of squid sec1 into squid axons led to the accumulation
of docked synaptic vesicles but prevention of fusion.
The antibody results reported here for GLUT4, and for
insulin secretion previously [33], appear incompatible with
the suggested active role for munc on fusion. How might these
seemingly opposing or unrelated e¡ects be manifested? It is
likely that munc is required for optimal fusion but it is also
clear that fusion can proceed in the absence of munc from in
vitro data using puri¢ed SNARE proteins in micelles [5]. The
antibody data presented here and previously [33] are consis-
tent with the possibility that removal of munc from predocked
vesicles can enable fusion. It is possible that munc peptides
described above interact with an e¡ector such as a Rab that
normally alters the conformation of munc, making it compe-
tent for fusion, perhaps priming syntaxin for fusion. Without
this interaction munc may remain bound to syntaxin and
fusion-incompetent, resulting in vesicles accumulating below
the cell surface. It is possible that antibody microinjection
sequesters munc, enabling fusion of vesicles in proximity to
the plasma membrane to proceed. Consistent with this, elec-
tron microscopy has demonstrated that a signi¢cant propor-
tion of GLUT4 vesicles lie in close proximity to the cell sur-
face [37]. It is clear that only when the nature of the
additional munc interacting proteins are de¢ned, including
how they impact syntaxin binding, will the complex role of
munc in fusion be understood.
In conclusion, our data show that manipulation of the level
of munc18c in cells modulates glucose transport. Over-expres-
sion of munc18c inhibits glucose transport in 3T3L1 cells
whereas reduced expression, by sequestering munc18c with
an antibody, stimulates glucose transport. Whether phosphor-
ylation plays a role in the regulation of munc activity remains
to be addressed but our studies do not support a direct role
for proline-directed kinase phosphorylation of the T569 site
a¡ecting the interaction of munc18c with syntaxin 4. Our
studies clearly support a regulatory role for munc18c in glu-
cose transport and indicate available protein level may be
involved in this regulation.
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